Post 200: Top D.C.-Area Businesses

2007 Post 200

Industries / Biotechnology

Company Annual Revenue Category
Celera Genomics Corp. $46.2 million Public Companies
Digene Corp. $152.9 million Public Companies
Emergent BioSolutions $152.7 million Public Companies
Human Genome Sciences Inc. $25.8 million Public Companies
Martek Biosciences $270.7 million Public Companies
MedImmune Inc. $1.3 billion Public Companies
PRA International $338.2 million Public Companies
United Therapeutics $159.6 million Public Companies
© The Washington Post Company